-+ 0.00%
-+ 0.00%
-+ 0.00%

Viatris Receives EMA CHMP Recommendation For Approval Of Ruxolitinib Viatris For The Treatment Of Myelofibrosis, Polycythaemia Vera And Graft-Vs-Host Disease

Benzinga·07/24/2026 10:35:41
Listen to the news

https://www.ema.europa.eu/en/medicines/human/EPAR/ruxolitinib-viatris